Product Description
_-Alanine supplementation has been shown to increase muscle carnosine levels and exercise performance. However, its effects on muscle recovery from resistance exercise (RE) remains unknown.Ê (Sourced from: https://pubmed.ncbi.nlm.nih.gov/30627787/)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral, Intravenous
FDA Designation: *
Approval Status: Approved
Approved Countries: Algeria | Australia | Austria | Belgium | Bosnia | Brazil | Chile | China | Colombia | Croatia | Cyprus | Egypt | France | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Lebanon | Malaysia | Malta | Mexico | Netherlands | New Zealand | Norway | Pakistan | Peru | Poland | Portugal | Russia | Serbia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam
Approved Indications: None
Company: Zai Lab
Company Location: Asia Pacific
Company Founding Year: 2013
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Austria, China, Germany, Spain
Active Clinical Trial Count: 5
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Kidney Transplant|Liver Transplant|Thrombocytopenia
Phase 2: Heart Transplant|Other
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
2024-511517-38-00 |
CL-N-CP-Paed | P2 |
Recruiting |
Other |
2027-09-30 |
2025-05-02 |
Treatments |
|
2023-510492-57-00 |
CL-N-HTX-Paed | P2 |
Recruiting |
Heart Transplant |
2027-03-31 |
2025-05-02 |
Treatments |
|
2024-512444-29-00 |
2024-512444-29-00 | P3 |
Recruiting |
Liver Transplant|Kidney Transplant |
2025-12-31 |
2025-05-02 |
Treatments |
|
2024-518174-13-00 |
CLN-LTX-III/08ESP/19 | P3 |
Not yet recruiting |
Liver Transplant |
2025-01-31 |
2025-05-02 |
Treatments |
|
CTR20130758 |
CTR20130758 | P3 |
Recruiting |
Thrombocytopenia |
None |
2025-04-29 |
Patient Enrollment|Treatments |